Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation by Celiz, Adam D. et al.
 1 
DOI: 10.1002/((please add manuscript number))  1 
Article type: Communication 2 
 3 
Discovery of a Novel Polymer Enabling Defined Human Pluripotent Stem Cell 4 
Expansion and Multi-Lineage Differentiation 5 
*Adam D. Celiz, *James G. W. Smith, Asha K. Patel, Andrew L. Hook, Divja Rajamohan, 6 
Vinoj T. George, Minal J. Patel, Vidana C. Epa, Taranjit Singh, Robert Langer,  Daniel G. 7 
Anderson, Nicholas D. Allen, David C. Hay, David A. Winkler, David A. Barrett, Martyn C. 8 
Davies, Lorraine E. Young, ★Chris Denning, ★Morgan R. Alexander.  9 
Dr. A. D. Celiz, Dr. A. L. Hook, T. Singh, Prof. M. C. Davies, Prof. M. R. Alexander 10 
Laboratory of Biophysics and Surface Analysis, School of Pharmacy, University of 11 
Nottingham, Nottingham, NG7 2RD, UK. 12 
 13 
Dr. A. D. Celiz 14 
Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 15 
02115, USA.  16 
 17 
Dr. J. G. W. Smith, Dr. A. K. Patel, Dr. D. Rajamohan, Dr. V. T. George, Dr. M. J. Patel, 18 
Prof. L. E. Young, Prof. C. Denning 19 
Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Medicine, 20 
Centre for Biomolecular Sciences, University of Nottingham, Nottingham, NG7 2RD, UK. 21 
 22 
Dr. A. K. Patel, Prof. D. G. Anderson, Prof. R. Langer 23 
David H. Koch Institute for Integrative Cancer Research, Department of Chemical 24 
Engineering, Institute for Medical Engineering and Science, Massachusetts Institute of 25 
Technology, Cambridge, MA02139, USA.  26 
 27 
Dr. V. C. Epa, Prof. D. A. Winkler 28 
CSIRO Manufacturing Flagship, 343 Royal Parade, Parkville 3052, Australia.  29 
Monash Institute of Pharmaceutical Sciences, 399 Royal Parade, Parkville 3052, Australia.   30 
 31 
Prof. N. C. Allen 32 
Cardiff School of Biosciences, The Sir Martin Evans Building, Museum Avenue, Cardiff, 33 
CF10 3AX, UK.  34 
 35 
Dr. D. C. Hay 36 
MRC Centre for Regenerative Medicine SCRM Building, The University of Edinburgh, 37 
Edinburgh bioQuarter, 5 Little France Drive, Edinburgh, EH16 4UU, UK.  38 
 39 
Prof. D. A. Barrett 40 
Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, 41 
Nottingham, NG7 2RD, UK. 42 
 43 
 2 
Keywords: high throughput, materials discovery, polymer microarrays, surface chemical 44 
analysis, human pluripotent stem cells 45 
 46 
* These authors contributed equally to this work  47 

 Joint corresponding authors 48 
 49 
Human pluripotent stem cells (hPSCs) have been proposed for various regenerative medicine, 50 
tissue engineering and drug discovery applications due to their ability to self-renew and be 51 
differentiated into numerous lineages representative of the three embryonic germ layers[1-4]. 52 
However, for the potential of hPSCs to be realized, bioprocessing-scale culture systems are 53 
required that can manufacture clinically relevant numbers of cells in an economical and 54 
reproducible manner. For example, to replace damaged tissue after a heart attack, it has been 55 
estimated that more than 1 billion cells would be needed for each patient[5]. To facilitate the 56 
transition from research to industrial scale production of adherent cell types, the ideal culture 57 
system should comprise of both defined medium and substrate that can be readily-used with 58 
existing cultureware from which a stem cell factory can be constructed12.  To meet this need, 59 
defined media formulations are available commercially for the expansion of hPSCs, including 60 
the widely-used StemPro[6] and mTeSR1[7]. These have improved reproducibility in hPSC 61 
culture by avoiding mouse embryonic fibroblast-conditioned medium (MEF-CM), the use of 62 
which remains commonplace and exhibits high batch variability[6-8]. Xenogenic components 63 
in the culture system create a barrier to clinical translation as they face greater regulatory 64 
hurdles. Nonetheless, there is still widespread use of the poorly-defined mouse sarcoma 65 
preparation, Matrigel™, as a cell attachment surface[9]. Therefore, the challenge is to find 66 
new materials from which to produce defined growth substrates for hPSCs that function with 67 
commercial defined media.   68 
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Polymeric materials show considerable promise as culture substrates due to their ease of 69 
manufacture from inexpensive, readily-available monomers and their industrial scalability[10]. 70 
High throughput screening methods have been used to accelerate the search for new polymers 71 
for hPSC culture since unbiased screening can be carried out with current knowledge of 72 
hPSC-substrate interactions[11-14]. Synthetic substrates identified using polymer microarrays 73 
have been shown to support the clonal growth of hESCs[15]. However, these materials require 74 
a preconditioning step with vitronectin, and scale up from the 300μm diameter micro array 75 
spots was not achieved. Despite these efforts, until now an effective polymeric growth 76 
substrate on which both hPSC expansion and subsequent differentiation can be induced has 77 
yet to be developed[10].  78 
In this report, we have achieved hPSC expansion on a xeno-free polymer substrate in defined, 79 
commercially available culture media (StemPro and mTeSR1) and multi lineage 80 
differentiation on the same polymer. A range of candidate polymers were identified using a 81 
high throughput screening microarray methodology developed to sample an unprecedented 82 
chemical space (141 monomers, polymerized alone and mixed to form 909 unique polymers, 83 
tested in 4356 individual assays). This allowed us to identify a novel copolymer substrate that 84 
achieves pluripotent hPSC expansion without the need for protein preconditioning. A simple 85 
procedure has been developed to coat standard cultureware, exemplified for the commonly 86 
used 6-well plate format. The same polymer was shown to support hPSC differentiation into 87 
representatives of the three germ layers, namely cardiomyocytes, hepatocyte-like cells and 88 
neural progenitors.  89 
 90 
A multi-generation high throughput polymer microarray screening methodology 91 
incorporating high throughput surface characterization (HT-SC)[16] was used to identify 92 
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materials that can support HUES7 (hESC) cell attachment and pluripotency in the widely 93 
used commercial defined, serum- and feeder-free medium, StemPro. The first-generation 94 
array, consisting of 141 monomers of wide chemical diversity, was printed using metal pins 95 
to transfer the liquid monomers onto poly(2-hydroxyethyl methacrylate) (polyHEMA) coated 96 
glass slides containing 6 replicates of each homopolymer (Figure 1a - monomer structures 97 
presented in Figure S1 and Table S1).[17] Polymer microarray spots of diameters ranging from 98 
250-400 μm were formed by UV photopolymerization using a modification of methods 99 
described previously [18,19] Arrays were preconditioned for 1 hour in StemPro medium prior 100 
to seeding with 1x106 HUES7 hESCs and culturing for 24 hours. Samples were fixed, stained 101 
for OCT4 expression (an indicator of pluripotency) and images acquired using an automated 102 
fluorescence microscope. Images were automatically processed to quantify cell response to 103 
each polymer spot (using CellProfiler software). This initial screen was used to identify 24 104 
‘hit’ materials on the basis of their ability to support high HUES7 hESC attachment across 105 
six replicates, whilst maintaining OCT4 expression (>90%) (Figure 1b and Figure 1c – ‘hit’ 106 
monomer structures presented in Figure S3).   107 
To explore the effect of copolymerization the 24 hit monomers were mixed pairwise in a 108 
combinatorial manner (70/30 v/v mixtures) to form a second-generation array design 109 
comprising 576 unique materials in triplicate (Figure 1d). Quantifying OCT4 positive HUES7 110 
cell attachment after 24 hours on the second-generation array in the same way as before 111 
identified a refined list of nine monomers that displayed high hPSC attachment as 112 
homopolymers and copolymers across the array (up to 100 cells/per spot) (Figure 1e - ‘hit’ 113 
monomer structures presented in Figure S3). Synergistic combinations of monomer were 114 
noted providing greater hPSC attachment than their homopolymer constituents. A third-115 
generation array was used to explore these hit monomers as copolymers at varied 116 
composition ratios to determine whether substrates could be improved further for HUES7 cell 117 
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attachment and maintenance of OCT4 expression during the first 24 hours of culture. The 9 118 
lead monomers were mixed combinatorially, utilizing additional ratios (10, 20, 30 and 40% 119 
v/v) to produce a third-generation array of 297 materials (Figure 1f). To make the assay more 120 
stringent in order to identify the most robust candidate polymers, the cell seeding density was 121 
reduced. This led to a significant reduction in cell attachment across the array, with only 90 122 
copolymers showing significant cell adhesion.  123 
 The best performing polymers in the third-generation array all contained monomer 5 (N-(4-124 
Hydroxyphenyl)methacrylamide) (HPMA), which was able to support HUES7 adhesion both 125 
as a homopolymer and as a copolymer (up to 56 ± 7 cells/per spot) (Figure 1g). Inclusion of 126 
HPMA as a minor component (10 – 40% v/v) with monomers that performed poorly as 127 
homopolymers dramatically increased the performance of the resulting copolymers. For 128 
example, monomer 26 (Lauryl methacrylate – M26) supported no attachment of hPSCs 129 
across the array as a homopolymer. However, inclusion of HPMA as a minor (10% v/v) or 130 
major (90% v/v) component with M26 increased hPSC attachment (Figure 1g). This “hit”, 131 
monomer supported the highest HUES7 cell attachment as a homopolymer within the third-132 
generation array. The increase in cell attachment by addition of other monomers was 133 
determined to be too small to justify taking forward any of the copolymer formulations and 134 
polyHPMA was defined as the lead candidate to be taken forward for hPSC expansion 135 
studies.  136 
High throughput surface characterization (HT-SC) was performed to determine the actual 137 
chemistry of the surface rather than assuming it to be the same as the bulk monomer 138 
composition. This has previously been shown to be important when copolymers are formed 139 
on slide, since surface segregation may result in unexpected surface chemistries and printing 140 
errors might lead to misidentification of hit materials[20,21]. Surface chemical analyses 141 
including time-of-flight secondary-ion mass spectrometry (ToF-SIMS), X-ray photoelectron 142 
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spectroscopy (XPS) and water contact angle (WCA) measurements were acquired from all 143 
polymers. No correlation between cell attachment and surface chemcial analysis could be 144 
found for the first- or second-generation arrays (Figure S4 and Figure S5). This is consistent 145 
with previous observations for stem cell-polymer interactions[15,21-23]. 146 
To investigate the excellent cell attachment performance of HPMA-containing copolymers in 147 
the third-generation array, the intensity of the ToF-SIMS ions characteristic to HPMA 148 
(C7H4NO2
-) and M26 (C9H11O2
+) were compared in the spectra of the homopolymers and 149 
copolymers (Figure S6). The intensity of the characteristic C7H4NO2
- secondary ion is highest 150 
in the polyHPMA homopolymer and decreased dramatically upon inclusion of M26. This can 151 
be explained by surface enrichment of M26, possibly in the monomer mixture prior to UV 152 
photopolymerization. The intensity of C9H11O2
+ secondary ion characteristic of M26 is 153 
consistent with this explanation. To quantify the amount of HPMA at the surface these 154 
materials, XPS analysis was employed using the elemental composition using nitrogen as a 155 
marker for polyHPMA (Figure 1h). The relative amount of nitrogen in polyHPMA 156 
homopolymer ([N]=4at%) is reduced by half upon inclusion of 10% M26 (1.9%). The 157 
amount of nitrogen in the XPS spectra follows a similar trend to the C7H4NO2
- ion in the ToF-158 
SIMS spectra for these materials confirming that M26 is enriched at the surface. Thus, 159 
despite there only being relatively low levels of polyHPMA at the surface of all copolymers 160 
than the uniform distribution expected of statistical copolymers, such small amounts are all 161 
that is required to encourage cell attachment, illustrated schematically for poly(HPMA-co-162 
P26) (90:10% v/v) in the third-generation microarray (Figure 1i).  163 
Focussing on the lead monomer, HPMA, scaled up materials of polyHPMA in 6-well plates 164 
were manufactured (see methods) and analyzed by ToF-SIMS to determine if the surface 165 
chemistry was consistent with polyHPMA in microarray spots. ToF-SIMS peaks 166 
characteristic of HPMA were observed at m/z = 108 and 109 (C6H6NO
+ and C6H7O
+ 167 
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respectively) from both microarray spots and from coatings scaled up to coat 6-well plates 168 
(Figure 1j). In the third-generation polymer microarray, we observed additional peaks at m/z 169 
= 45 and 113 (C2H5O
+ and C6H9O2
+ respectively), which are characteristic of polyHEMA 170 
(Figure 2c). This indicated that the underlying polyHEMA support material had intermixed 171 
with the deposited monomers to be present at the surface of these spots of this array. Given 172 
the high level of hPSC attachment on the polyHPMA spots in the third-generation polymer 173 
microarray (Figure 1g), we reasoned that polyHEMA might be a beneficial additive and 174 
explored this as a co-monomer in scale up.  175 
 For wide applicability, a synthetic culture substrate needs to be optically transparent, cost-176 
effective, compatible with common TCPS cultureware and be scaled up to coat cultureware 177 
that could support the expansion of cells at an industrial scale. Previously, promising 178 
materials for hPSC culture identified on polymer microarrays have been restricted to use as 179 
arrayed spots or small growth areas such as coated coverslips or slides incompatible with 180 
scalable cell manufacture[12,13,15]. To demonstrate scale up from the microarray spots we 181 
developed a method to coat commonly used polystyrene cultureware with HPMA.  182 
Scale up to well plates of polyHPMA using in situ UV polymerization methods were 183 
unsuccessful because of difficulty removing unpolymerised residual monomer (as detected by 184 
ToF-SIMS) from the thick polymer coatings, which caused cell death (Figure S7 and 185 
Supplementary Methods). We therefore employed a prepolymerization approach where 186 
solution of polyHPMA was presynthesized and subsequently coated onto plasma etched 187 
tissue culture polystyrene (PE-TCPS) cultureware (see methods and Figure S8). Using a 188 
prepolymerized solution to coat cultureware is convenient as large quantities of polymer can 189 
be synthesized in one batch that can be applied in a simple coating procedure, which can be 190 
performed routinely by hand or by industrial automation using existing TCPS manufacturing 191 
procedures that involves plasma activation[24]. The substrate formed after evaporation of an 192 
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ethanolic polyHPMA solution was transparent, however cracking was observed after solvent 193 
evaporation that developed on storage in cell culture incubators (Figure S9). Given that low 194 
levels of HEMA were detected in the polyHPMA micro arrays (Figure 1k) we chose this 195 
monomer to copolymerize with HPMA to prevent cracking. 196 
The poly(HPMA-co-HEMA) copolymer was synthesized and characterized in the same 197 
manner as polyHPMA (Figure S10 and Supplementary methods). Coatings consisting of 198 
poly(HPMA-co-HEMA) gave transparent wells which did not exhibit cracks after extended 199 
immersion in culture media (1 month) (Figure S11).  ToF-SIMS analysis confirmed that 200 
HPMA and HEMA moieties were present at the surface of these materials (Figure 2d). To 201 
provide a quantitative elemental and functional characterization of the surface chemistry, 202 
XPS analysis was performed (Figure 2e and Figure S12). XPS analysis of polyHPMA from 203 
the array format revealed a lower elemental nitrogen content ([N] = 4.0 at%) compared to 204 
scaled up polyHPMA and poly(HPMA-co-HEMA) (8.7% and 7.7% respectively). These 205 
measurements indicate the presence of the polyHEMA from the underlying substrate 206 
diffusing to the surface of the arrayed material during the printing process and supports the 207 
ToF-SIMS analysis that discovered increased HEMA moieties and decreased HPMA 208 
moieties compared to the spectra of polyHPMA and poly(HPMA-co-HEMA). The 209 
prepolymerized material can also be seen to have approximately 10 mol% HEMA at the 210 
surface. The high quality transparent coatings and presence of HPMA and HEMA chemical 211 
moieties at the surface meant that poly(HPMA-co-HEMA)-coated cultureware provided a 212 
suitable substrate to evaluate hPSC expansion. 213 
Adopting the conditions identified above to fabricate poly(HPMA-co-HEMA) coated 6-well 214 
plates permitted attachment of hPSCs and their proliferation to confluence. We next sought to 215 
evaluate maintenance of pluripotency to determine whether hPSCs could conform to accepted 216 
criteria, including serial propagation for at least 5 passages whilst retaining karyotype 217 
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stability and expression of pluripotency markers, as well as differentiation to representatives 218 
of the three embryonic germ layers (mesoderm, endoderm and ectoderm). We evaluated 219 
whether substrate preconditioning with culture medium or ECM proteins was a necessary 220 
step. Comparison of hPSCs seeded with or without preconditioning showed similar levels of 221 
attachment and distribution after 24 hours in StemPro. Similarly, medium exchanges led to 222 
expansion to confluency by 72 hours in both conditions (Figure 2a). Therefore, 223 
preconditioning was omitted during subsequent passages.  224 
Propagation through 5 serial passages with accutase on the poly(HPMA-co-HEMA) substrate 225 
showed a consistent population doubling index of 81.3 +/- 8.5 hours (Figure 2b), retention of 226 
46X,Y karyotype by G-banding of 30 cells (Figure S13) and expression of OCT4, TRA181 227 
and SSEA4 in >93% cells, as measured by quantitative immunofluorescence using an 228 
automated plate reader (Operetta®) and high-content image analysis software (CellProfiler) 229 
(Figure 2c, Figure 2d and Figure 2e).  230 
We sought to test whether the poly(HPMA-co-HEMA) substrate could support pluripotent 231 
expansion of hESC and hiPSC lines in different commercial culture media. Thus, cultures of 232 
the HUES7 hESC line and BT1 hiPSC line were initiated in StemPro and another commonly-233 
used defined medium, mTeSR1[7]. In each case, consistent population doubling times were 234 
observed through 5 serial passages in the absence of any preconditioning step (Figure 2b). 235 
There was also retention of stable karyotype (46,XY for HUES7; 46,XX for BT1) (Figure 236 
S13), and pluripotent markers of OCT4, TRA181 and SSEA4 by immunofluorescence (all 237 
>88%) (Figure 2c and Figure 2d). Poly(HPMA-co-HEMA)-coated cultureware can be stored 238 
for at least 6 months at ambient conditions and can be used off-the-shelf in the same way as 239 
general TCPS cultureware (Figure S14). 240 
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Since coupling hPSC expansion with differentiation would increase the utility of an 241 
expansion substrate, we sought to evaluate whether the formation of representatives of each 242 
of the three germ layers during human development could be induced by directing 243 
differentiation on poly(HPMA-co-HEMA). 244 
We directed formation of cardiomyocytes (mesoderm) by culturing two-dimensional 245 
monolayers of hPSCs on poly(HPMA-co-HEMA) with modulators of TGF-b superfamily 246 
(activin A and BMP4)[25] and WNT (KY02111[26] and XAV393[27]) pathways. In the same 247 
time course as hPSCs differentiated on Matrigel (12 days), beating clusters of 248 
cardiomyocytes formed (see Supplementary Video 1), which were shown by immunostaining 249 
to be positive for α-actinin and cardiac troponin-T staining (Figure 3a and Figure 3b). 250 
Functional analysis of the differentiated cells by patch clamp showed they had 251 
electrophysiological characteristics similar to those previously published for hPSC-252 
cardiomyocytes[28], including a mean action potential duration (APD) of 417+102 ms (Figure 253 
4c). Based on 90% / 50% repolarization values (APD90/APD50), these cultures contained 254 
ventricular (APD90/APD50 of ≤ 1.3), atrial (≥ 1.8) and pacemaker (1.4-1.7) cardiomyocyte 255 
subtypes[29] (Figure 3d). 256 
Directed hepatocyte differentiation (endoderm) was achieved via an 18 day protocol[30] using 257 
activin-A, Wnt3a, FGF, HGF and oncostatin-M to modulate signaling cascades. 258 
Differentiated cell cultures on poly(HPMA-co-HEMA)-coated substrate expressed albumin, 259 
AFP, HNF4A and A1AT and secreted AFP with comparable efficiency to Matrigel-coated 260 
controls (Figure 3e, Figure 3f and Figure 3g).  261 
Finally, we induced hPSC differentiation to neural progenitors, which arise from the 262 
ectoderm germ layer. Dual SMAD-inhibition[31,32] with dorsomorphin and SB431542 for 263 
seven days induced the formation of neural rosette-like colonies on poly(HPMA-co-HEMA) 264 
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substrates (Figure 3h, Figure 3i and Figure 3j).  Neural progenitors produced on Matrigel and 265 
poly(HPMA-co-HEMA) displayed similar levels of PAX6 and SOX1 markers (PAX6: 78% ± 266 
4% and 74% ± 8%; SOX1: 68% ± 11% and 69% ± 18% respectively). 267 
In order to determine a mechanism for the hPSC adhesion to poly(HPMA-co-HEMA), 268 
antibody blocking assays were performed for key hPSC integrins. Blocking of the integrins 269 
β1 and αVβ5 resulted in a significant reduction (>30%) in hPSC attachment to poly(HPMA-270 
co-HEMA) when cultured in StemPro media (Figure 4a, Figure 4b and Figure 4c). Although 271 
hPSCs have been shown to express numerous integrins, including those of the α1, α2, α3, α5, 272 
α6, α7, αV and α11, and β1, β2, β3 and β5 families[9,33-36], only α2, α5, α6, αV and β1 integrins 273 
have been shown to play a significant role in hPSCs adhesion to Matrigel coated culture 274 
surfaces[37,38], and only αV integrins in hPSC adhesion to polymer culture surfaces without 275 
matrix coatings[15]. This is therefore the first report demonstrating a role for β1 as well as αV 276 
integrins in hPSCs adhesion to polymer culture surfaces without matrix coatings. Although 277 
individually αVβ5 binds vitronectin sites and β1 binds fibronectin and laminin sites[37], it is 278 
likely that these two integrins interact in a complex manner to promote hPSC adhesion to 279 
sites present in the poly(HPMA-co-HEMA) chemistry or to proteins (most likely albumin) 280 
adsorbed from the medium  (Figure 4d).   281 
In summary, we have used a high throughput combinatorial approach to identify and develop 282 
a defined, synthetic polymeric substrate that supports hPSC pluripotency and expansion 283 
through serial passage in commercial defined media without the need for protein pre-284 
adsorption. This was achieved for both hESCs and hiPSCs. Additionally, directed 285 
differentiation was achieved on the hit polymer, poly(HPMA-co-HEMA), to representatives 286 
of each of the three germ layers, including cardiomyocytes (mesoderm), hepatocyte-like cells 287 
(endoderm) and neuro-ectoderm (ectoderm). Thus, poly(HPMA-co-HEMA) fulfills all the 288 
current culture requirements for the clinical use of stem cells within regenerative medicine 289 
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and can be scaled up by coating onto cultureware to be used off-the-shelf, providing a cost-290 
effective alternative to commercially available hPSC expansion substrates. The expansion of 291 
hPSCs and production of terminally differentiated cell types without the influence of 292 
undefined and xenogenic matrix protein coatings provides a robust platform for the industrial 293 
scale production of hPSCs for regenerative medicine applications and therapies. 294 
 295 
Experimental 296 
Preparation of polymers: polyHPMA and poly(HPMA-co-HEMA) were prepared via a 297 
thermally initiated free radical polymerization in an ethanolic solution with the addition of 298 
2,2’-azobis(2-methylpropionitrile) (AIBN – 1% w/w to HPMA). The isolated and dried 299 
polymers were dissolved in ethanol (5% w/v) and added into TCPS 6-well to cover the base 300 
of each well plate directly after oxygen plasma activation. The solvent was allowed to 301 
evaporate under ambient conditions for 24 hours prior to hPSC culture. Complete detailed 302 
methodolody of polymer synthesis, characterization and all cell culture protocols can be 303 
found in the supporting information. 304 
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Figure 1.  Multi-generation microarray screening strategy and high throughput surface 420 
characterization. (a) A first-generation array of wide chemically diversity consisting of 141 421 
monomers was used to screen for hPSC attachment. (b) Materials were ranked by hPSC 422 
attachment (six replicates) after 24 hours in culture whereupon cells were quantified by DAPI 423 
and OCT-4 staining. (c) Phase (left) and fluorescence (right) images of an example ‘hit’ 424 
material from the first-generation. Scale bar = 250 µm. Fluorescence image is a combined 425 
image of both DAPI (ex = 410 nm, em = 470 nm) and OCT4  (ex = 530 nm, em = 630 nm). 426 
(d) 24 ‘hit’ materials were mixed pairwise in a combinatorial manner to produce a second-427 
generation of 576 unique materials. (e) These materials were assessed and ranked in a similar 428 
way to the first-generation array. (f) A third-generation array was printed from 9 common 429 
monomers that formed the hit copolymers in the second-generation array but were mixed in 430 
further ratios to form an array of 297 materials. (g) Materials were ranked to identify lead 431 
compositions for scale up. (h) XPS analysis of polyHPMA, P26 and copolymers thereof to 432 
determine the actual surface chemistry. Line is drawn to guide the eye. (i) Proposed surface 433 
chemistry of poly(HPMA-co-P26) (90:10% v/v) identified from ToF-SIMS and XPS analysis 434 
of third-generation microarray. (j) ToF-SIMS and (k) XPS analysis of polyHPMA in the 435 
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third-generation array revealed polyHEMA at the surface which was incorporated as a co-436 
monomer for scaled up polymers to assess hPSC expansion. 437 
 438 
 439 
Figure 2. hPSC expansion through serial passage. (a) Phase images showing that hESCs and 440 
hiPSCs were able to attach to poly(HPMA-co-HEMA) substrates at 24h in and expand to 441 
confluence and compaction at 72h. (b) Growth curves for hESCs and hiPSCs showing 442 
consistent cell population doubling (CPD) times on (☐) poly(HPMA-co-HEMA) versus (O) 443 
Matrigel controls for 5 passages for varied media conditions. (c) Positive 444 
immunofluorescence for pluripotent markers OCT4, TRA181 and SSEA4 following serial 445 
passaging of hPSCs on poly(HPMA-co-HEMA). Scale bar = 250 µm. (d) hPSCs on 446 
poly(HPMA-co-HEMA) maintain comparable pluripotent marker expression levels versus 447 
Matrigel controls, with OCT4, TRA181 and SSEA4 expression >88%  (e) Example of 448 
automated high content image analysis displaying DAPI (white line) and OCT4 (yellow line) 449 
positive HUES7 cells on poly(HPMA-co-HEMA) in mTeSR1 medium. Scale bars = 100 µm 450 
(left image) and 10 µm (right image). 451 
  452 
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 453 
Figure 3. Three germ layer directed differentiation of hPSCs on polymeric substrate.  (a) 454 
Mesoderm differentiation on poly(HPMA-co-HEMA) induced positive α-actinin and cardiac 455 
troponin-T expression. Scale bar = 50 µm (b) Quantification of positive cardiac marker 456 
expression on poly(HPMA-co-HEMA) and matrigel displayed similar levels. (c) 457 
Electrophysiology of the spontaneously beating cardiomyocytes on poly(HPMA-co-HEMA) 458 
showed ventricular (APD90/APD50 of ≤ 1.3), atrial (≥ 1.8) and pacemaker (1.4 - 1.7) 459 
subtypes of cardiomyocytes, (d) with a mean action potential duration (APD) of 417 ± 102 460 
ms (e) Endoderm differentiation on poly(HPMA-co-HEMA) induced hepatic marker 461 
expression (Scale bar = 100 µm)  (f) in hepatocyte-like cells with active AFP secretion (g) 462 
Quantification of positive hepatocyte marker expression on poly(HPMA-co-HEMA) and 463 
matrigel displayed similar levels. (h) Ectoderm differentiation on poly(HPMA-co-HEMA) 464 
induced neurogenesis marker expression (Scale bar = 100 µm) (i) Quantification of positive 465 
neuroectoderm marker expression on poly(HPMA-co-HEMA) and Matrigel displayed similar 466 
levels. (j) PAX6 positive neural rosette formation on poly(HPMA-co-HEMA) following 467 
ectoderm differentiation (Scale bar = 1 mm).  468 
 469 
  470 
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 471 
 472 
Figure 4. Integrin blocking of hESCs on poly(HPMA-co-HEMA). hESCs adhered to 473 
poly(HPMA-co-HEMA) actively express the integrins (a) β1 and (b) αVβ5. Scale bar = 50 μm 474 
(c) Following the blocking of the integrins β1 and αVβ5 there is a significant reduction in 475 
hPSC adhesion to poly(HPMA-co-HEMA) in StemPro media. (d) Schematic of proposed 476 
hPSC adhesion mechanism through integrin binding to adsorbed media proteins on 477 
poly(HPMA-co-HEMA). 478 
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